Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity

Eye (Lond). 2010 May;24(5):931-3. doi: 10.1038/eye.2009.156. Epub 2009 Jun 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Fibrosis
  • Humans
  • Infant, Newborn
  • Male
  • Retinal Detachment / etiology
  • Retinal Detachment / surgery
  • Retinal Vessels / pathology*
  • Retinopathy of Prematurity / drug therapy*
  • Vitrectomy

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab